April 27, 2026 · Form 4 insider transaction
Harford Simon N.R. sold 143,595 shares of Amicus Therapeutics, Inc. at $14.50 per share, a transaction worth $2.08M. The trade was recorded as disposition to the issuer and disclosed on an SEC Form 4, filed 0 days after the transaction.
The reported securities were disposed of in connection with consummation of the acquisition of the Issuer by BioMarin Pharmaceutical Inc. (the "Merger"), which included 108,478 shares of Common Stock and 35,117 restricted stock units (which vested in full in connection with consummation of the Merger).